Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.38 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.34 |
| ▸ | BUB1 | O43683 | 1/20 | 0.34 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28974037 | 0.90 | LMNA (0.41) | USP2SMN1; SMN2DDB1CRBNCHRM2 | |
| SCHEMBL513188 | 0.87 | USP2 (0.43) | USP2SMN1; SMN2DDB1CRBNCHRM2 | |
| SCHEMBL3738925 | 0.81 | CHRM2 (0.40) | USP2SMN1; SMN2DDB1CRBNCHRM2 | |
| SCHEMBL10199690 | 0.81 | — | — | |
| Tetrahydrofuran SCHEMBL28264888 | 0.80 | USP2 (0.50) | USP2SMN1; SMN2DDB1CRBNCHRM2 | |
| SCHEMBL6519434 | 0.80 | CHRNA7 (0.36) | USP2SMN1; SMN2DDB1CRBNCHRM2 | |
| SCHEMBL205421 | 0.80 | LMNA (0.48) | USP2SMN1; SMN2CHRM2CHRM1CHRM3 | |
| SCHEMBL7495565 | 0.79 | LMNA (0.47) | USP2SMN1; SMN2CHRM2CHRM1CHRM3 | |
| SCHEMBL42476 | 0.79 | SMN1; SMN2 (0.48) | USP2SMN1; SMN2CHRM2CHRM1CHRM3 | |
| SCHEMBL31551856 | 0.77 | SMN1; SMN2 (0.50) | USP2SMN1; SMN2CHRM2CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 365 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107108604-B | Process for preparing tricyclic lactam compounds | 豪夫迈·罗氏有限公司 | 2020-07-24 | — | — | CN | claimed |
| EP-3237903-B1 | METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS | EXXONMOBIL RES & ENG CO (US) | 2020-02-26 | — | — | EP | claimed |
| EP-3212645-B1 | PROCESS FOR MAKING TRICYCLIC LACTAM COMPOUNDS | HOFFMANN LA ROCHE (CH) | 2018-11-28 | — | — | EP | claimed |
| US-9969735-B2 | Process for making tricyclic lactam compounds | GENENTECH, INC. (US) | 2018-05-15 | — | — | US | claimed |
| US-20170313704-A1 | PROCESS FOR MAKING TRICYCLIC LACTAM COMPOUNDS | GENENTECH, INC. (US) | 2017-11-02 | — | — | US | claimed |
| EP-3237903-A1 | METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS | Exxonmobil Research And Engineering Company (US) | 2017-11-01 | — | — | EP | claimed |
| EP-3237904-A1 | METHODS FOR DETERMINING CONDITION AND QUALITY OF PETROLEUM PRODUCTS | Exxonmobil Research And Engineering Company (US) | 2017-11-01 | — | — | EP | claimed |
| EP-3212645-A1 | PROCESS FOR MAKING TRICYCLIC LACTAM COMPOUNDS | F. Hoffmann-La Roche AG (CH) | 2017-09-06 | — | — | EP | claimed |
| WO-2016106211-A1 | METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-06-30 | — | — | WO | claimed |
| US-20160187315-A1 | METHODS FOR DETERMINING CONDITION AND QUALITY OF PETROLEUM PRODUCTS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-06-30 | — | — | US | claimed |
| WO-2016106214-A1 | METHODS FOR DETERMINING CONDITION AND QUALITY OF PETROLEUM PRODUCTS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-06-30 | — | — | WO | claimed |
| US-20160187314-A1 | METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-06-30 | — | — | US | claimed |
| WO-2016066490-A1 | PROCESS FOR MAKING TRICYCLIC LACTAM COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2016-05-06 | — | — | WO | claimed |
| US-20260132143-A1 | HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF | AMGEN INC. (US) | 2026-05-14 | — | — | US | disclosed |
| EP-4055016-B1 | GPR52 MODULATOR COMPOUNDS | NXERA PHARMA UK LTD (GB) | 2026-04-29 | — | — | EP | disclosed |
| US-20260103474-A1 | NOVEL COMPOUNDS FOR THE DIAGNOSIS OF TDP-43 PROTEINOPATHIES | AC IMMUNE SA (CH) | 2026-04-16 | — | — | US | disclosed |
| US-20050043346-A1 | Pyridylpyrrole derivatives active as kinase inhibitors | PHARMACIA ITALIA S.P.A. (IT) | 2005-02-24 | — | — | US | disclosed |
| US-20050043323-A1 | Pyrimidylpyrrole derivatives active as kinase inhibitors | PHARMACIA ITALIA S.P.A. (IT) | 2005-02-24 | — | — | US | disclosed |
| WO-2005013986-A1 | PYRIDYLPYRROLE DERIVATIVES ACTIVE AS KINASE INHIBITORS | PHARMACIA ITALIA S.P.A. (IT) | 2005-02-17 | — | — | WO | disclosed |
| WO-2005014572-A1 | PYRIMIDYLPYRROLE DERIVATIVES ACTIVE AS KINASE INHIBITORS | PHARMACIA ITALIA S.P.A. (IT) | 2005-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050043346-A1 | Pyridylpyrrole derivatives active as kinase inhibitors | MAP3K6, MAP3K5, MAP4K2 | USP2 3374/4885SMN1; SMN2 2469/4885DDB1 1516/4885 |
| US-20170313704-A1 | PROCESS FOR MAKING TRICYCLIC LACTAM COMPOUNDS | COASY, MRPL21, SBDS | USP2 1465/4885SMN1; SMN2 3036/4885DDB1 2404/4885 |
| US-20050043323-A1 | Pyrimidylpyrrole derivatives active as kinase inhibitors | TYMP, DTYMK, DCK | USP2 3550/4885SMN1; SMN2 2627/4885DDB1 939/4885 |
| US-20260132143-A1 | HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF | KRAS, NRAS, HRAS | USP2 1960/4885SMN1; SMN2 2043/4885DDB1 487/4885 |
| US-20260103474-A1 | NOVEL COMPOUNDS FOR THE DIAGNOSIS OF TDP-43 PROTEINOPATHIES | TARDBP, FUS, HNRNPH3 | USP2 1769/4885SMN1; SMN2 32/4885DDB1 97/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.